| Open Trial |
Description |
| Phase I/II |
Lovastatin in advanced and metastatic carcinoma of the cervix or head and neck. 11 patients
Study Nurse: Soo Chin |
| NCIC OV 14 |
TEC vs TP for sub-optimally debulked advanced ovarian cancer.2 patients
Study Nurse: Sheila Webster/Soo Chin |
| NCIC OV15 |
Phase III - International Randomized Phase III Study Comparing Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients with Advanced Epithelial Ovarian Carcinoma Who Failed First Line Platinum-Based Therapy. 2 patients
Study Nurse: Sheila Webster/Soo Chin |
| NCIC OV16 |
Randomized Phase 3 study comparing taxol/carbo vs sequential couplets of topotecan/carbo followed paclitaxel/carbo. |
| NCIC IND 126 |
Phase II trial of letrozole in advanced or recurrent endometrial cancer. 15 patients
Study Nurse: Pat Merante |
| |
Phase I Gemcitabine/cisplatin + XRT in locally advanced cervix ca.
Study Nurse Dianne Taylor |
| |
Phase II trial of Cisplatin and Topotecan in recurrent ovarian cancer. 7 patients
Study Nurse - Sheila Webster/Soo Chin |
| |
Phase II trial of Cisplatin and Topotecan in advanced and metastatic carcinoma of the cervix |
| |
Phase II trial of carboplatin and caelyx in advanced uterine malignancies - 8 patients
Study Nurse - Sheila Webster/Soo Chin |
| |
Phase I/II trial of cox-2 inhibitor before and during concurrent chemoradiation (cisplatin) for locally advanced cervix cancer - 9 patients
Study Nurse - Soo Chin |
| Platinum Refractory: |
Phase II study of Epothilone in patients with refractory/resistant ovarian cancer
NCIC IND 149 Phase II study of OSI-774 + Carbo in ovarian cancer. |
| Platinum Sensitive (> 6 months) |
Phase II trial of Cisplatin and Topotecan in recurrent ovarian cancer |
| NCIC IND 149 |
Phase II study of OSI-774 in metastatic endometrial cancer. |
| |
IND 149 -OSI 774 + Carbo |
| Endometrial/Uterine |
| NCIC IND 148 |
Phase II study of OSI-774 and Carbo in recurrent endometrial cancer
First Line Chemotherapy (also allow MMMT, Ca cervix)
Phase II trial of carboplatin and caelyx in advanced uterine malignancies |
| Cervix |
| Secondary Chemoprevention |
Chemoprevention trial of vioxx in high grade cervix and vulva intraepithelial neoplasia and oral-pharyngeal leukoplakia
Initial therapy
Phase I/II trial of cox-2 inhibitor before and during concurrent chemoradiation (cisplatin) for locally advanced cervix cancer
Recurrent Disease
Phase I/II Lovastatin in advanced and metastatic carcinoma of the cervix or head and neck
Carboplatin/Caelyx |
| |
Chemoprevention trial of vioxx in high grade cervix and vulva intraepithelial neoplasia and oral-pharyngeal leukoplakia - 1 H&N; 4 Cx screened |
| Upcoming: |
| NCIC IND 148 |
Phase II study of OSI-774 and carboplatin in recurrent ovarian cancer. |
| |
Randomized Phase 2 Study of CI-1033 in patients with advanced ovarian cancer. |
| |
Phase II study of Epothilone in patients with refractory/resistant ovarian cancer. |
| |
Phase II trial of Cisplatin and Topotecan in advanced and metastatic carcinoma of the cervix 2. |
| |
Phase II study of BAY 38-3441 in patients with recurrent, metastatic or unresectable ovarian cancer. |
Clinical Trials on Ovarian, Cervix and Endometrial/Uterine Cancer
PDF Format
More Clinical Trials for Princess Margaret Hospital
PDF Format |
